Torque teno viruses (TTVs) are vertebrate infecting, single-stranded circular DNA viruses. Two genetically distinct TTV genogroups (TTV1 and TTV2) infect swine worldwide with high prevalence. Currently, swine TTVs are considered non-pathogenic, although TTV2 has been linked to post-weaning multisystemic wasting syndrome, a porcine circovirus disease. On the other hand, pig materials are an important source of components used in porcine vaccine manufacturing, human drugs and commercial enzyme products. However, there is little information about the possible existence of extraneous viruses in products containing porcine-derived components. In the present study, 26 commercial swine vaccines, seven human drugs and three enzyme products from porcine origin were tested for the presence of TTV1 and TTV2 genomes by PCR. Four vaccines against Mycoplasma hyopneumoniae were positive for TTV2 by PCR. Three M. hyopneumoniae, one porcine parvovirus and one porcine reproductive and respiratory syndrome virus vaccines were PCR positive for TTV1. One human drug contained TTV1 DNA as well as a trypsin enzyme; a porcine-derived elastase product was positive for both TTV genogroups. These results show that swine TTVs are contaminants not only of swine vaccines but also of human drugs containing porcine components and enzymes for laboratory use.
INTRODUCTION
Torque teno viruses (TTVs, floating genus Anellovirus) are small icosahedral, single-stranded circular DNA viruses infecting humans, non-human primates, and farm and wild animals Okamoto et al., 2002; Martinez et al., 2006) . TTVs are species-specific, ubiquitous and currently considered non-pathogenic (Kekarainen & Segalés, 2008) . These viruses are assumed to be transmitted vertically and by the faecal-oral route (Okamoto et al., 1998; Matsubara et al., 2001; Maggi et al., 2003; Komatsu et al., 2004; Kekarainen et al., 2007) . TTVs from different species share conserved genomic organization but are distinct in their nucleotide sequences (Inami et al., 2000; Okamoto et al., 2001 Okamoto et al., , 2002 Niel et al., 2005) .
In swine, two distinct genogroups, TTV1 and TTV2, often co-infecting the same animal, have been identified (Bigarré et al., 2005; Niel et al., 2005; Kekarainen et al., 2006; Martinez et al., 2006) . The prevalence of swine TTVs varies between different studies, ranging from 24 to 100 % (McKeown et al., 2004; Bigarré et al., 2005; Kekarainen et al., 2006; Martelli et al., 2006) . Only a few studies have focused on both genogroups (Niel et al., 2005; Kekarainen et al., 2006; Martinez et al., 2006; Kekarainen et al., 2007; Segalés et al., 2008) and in one of them, a significant association of TTV2 with the economically important postweaning multisystemic wasting syndrome (PMWS), a porcine circovirus disease, has been described . but is incapable of eliminating TTV (Azzi et al., 2006) . Clotting factor concentrates subjected to heat treatment as a viral inactivation step were negative for human TTV, but positive for TTV after solvent/detergent treatment (Simmonds et al., 1998) . Furthermore, waste and river waters are shown to be contaminated with human TTV (Haramoto et al., 2005; Verani et al., 2006; Diniz-Mendes et al., 2008) .
To date, no research has been carried out on the presence of swine TTVs in commercial products used for pigs or even drugs for human use that include porcine components. Therefore, in the present study, 26 commercially available swine vaccines, seven human drugs containing products of pig origin and three swine-derived enzymes commonly used in human medicine were tested for the presence of the two known swine TTV genogroups.
METHODS
Pig vaccines, human drugs and enzyme products. Twenty-six commercial swine vaccines produced by eight different manufac-turers, seven human drugs produced by seven manufacturers and three commercial porcine-derived enzymes for laboratory use also from three different manufacturers were included in this study (Table  1) . Lyophilized vaccines were reconstituted in water and commercial porcine-derived products in PBS (5 mg ml 21 ).
PCR to detect swine TTVs. DNA from the above-mentioned samples was extracted from 200 ml of product solutions by using the NucleoSpin Blood DNA extraction kit (Macherey-Nagel) and eluted in 100 ml elution buffer. DNA from low molecular mass heparins and laboratory enzymes was extracted as described above, with (to inhibit enzymic activity of products at 65 uC for 2 h) and without inactivation.
To determine if samples were positive for TTVs, two distinct PCR approaches were used: one utilizing previously described degenerate TTV primers (Bigarré et al., 2005) and another genogroup-specific PCRs (Segalés et al., 2008) . Amplification using degenerate primers was done as described previously (Bigarré et al., 2005) , except for the amount of each primer (100 pmol), temperature of hybridization (58 uC) and number of cycles of amplification (50). For TTV1specific PCR, 25 ml PCRs contained 3 ml extracted DNA, 10 pmol primer forward-1 (59-CGGGTTCAGGAGGCTCAAT-39) and reverse-1 (59-GCCATTCGGAACTGCACTTACT-39), 0.4 mM dNTP, 2 mM MgCl 2 and 0.75 U Taq DNA polymerase (FlexiGo Taq; Promega). Amplification was initiated by heating for 5 min at 94 uC, followed by On: Fri, 28 Dec 2018 11:12:10 50 cycles of 15 s at 94 uC, 20 s at 54 uC, 30 s at 72 uC and a final extension for 5 min at 72 uC. For TTV2, amplification was carried out as described above but with annealing at 56 uC, using primer pairs forward-1 (59-TCATGACAGGGTTCACCGGAA-39) and reverse-1 (59-CGTCTGCGCACTTACTTATATACTCTA-39). Amplification products (15 ml), of expected sizes 314 (TTV1) and 252 bp (TTV2), were analysed on a 1.8 % TAE agarose gel. Positive samples were confirmed by sequencing both strands of PCR products using Big Dye Terminator v3.1 cycle sequencing kit (Applied Biosystems) using an ABI Prism 3100 sequence analyser (Perkin Elmer). Sequences were edited using the VectorNTI program.
To evaluate if samples contained compounds inhibiting the PCR, previously negatively tested products were spiked with 100 ng plasmid containing the TTV2 PCR amplification product prior to DNA extraction. TTV2 PCR was performed on spiked samples as described above.
Phylogenetic analysis. Nine of the obtained sequences (five for TTV1 and four for TTV2) were aligned by using the CLUSTAL W program. Phylogenetic and molecular evolutionary analyses were conducted using MEGA version 3.1 (Kumar et al., 2004) . Nucleotide sequence alignments were used to calculate phylogenetic distances using the Jukes-Cantor model. Phylogenies were inferred from distance matrices using the neighbour-joining method. Statistical significance of the branching was estimated using SEQBOOT (1000 resamplings) and, from these, a consensus tree was built.
RESULTS
Six of 26 pig vaccines tested positive for one or the other swine TTV (Table 1) . More specifically, five vaccines were PCR positive for TTV1, while four were PCR positive for TTV2; three of those vaccines contained both TTV1 and TTV2 genomes. In regards the type of vaccines yielding positive PCR results, all four tested swine vaccines against Mycoplasma hyopneumoniae were positive for TTV2 PCR and three of them positive for TTV1 PCR as well. These vaccines were manufactured by three different commercial companies. Two additional pig vaccines, against parvovirus (PPV) and porcine reproductive and respiratory syndrome virus (PRRSV), were PCR positive for TTV1, but negative for TTV2.
One human drug contained detectable levels of TTV1 genome as well as two porcine-derived laboratory enzymes;
one of the enzymes, elastase, was positive for both TTV genogroups (Table 2) .
Results from PCRs with degenerate primers were the same as with TTV1-or TTV2-specific primers. However, amplification products from degenerate primers were between 100 and 120 bp and depending on the sample, additional, larger bands could be seen on an analytical gel.
The sequence identities with published TTV sequences available at the GenBank database were from 89 to 99 % and from 91 to 98 % for TTV1 and TTV2, respectively. The phylogenetic analysis showed clear clustering of TTV1 and TTV2 (Fig. 1) , but no specific grouping of the obtained sequences within genogroups was observed.
All products that yielded negative results by PCR for TTVs were tested after being spiked with a TTV2 plasmid. From 27 spiked initially PCR-negative products, 17 were found to be positive by PCR. All human drugs (but the one based on pancreatic enzymes that was already positive by TTV1 PCR and, therefore, not tested), one laboratory enzyme and three porcine vaccines were negative after spiking.
DISCUSSION
The biological nature of vaccines implies a risk for contamination with extraneous agents (Bruckner & Ottiger, 2007) . Therefore, manufacturing processes and quality control assessment should guarantee vaccines free from extraneous agents, as indicated by the European Pharmacopoeia (EP). Recommended methods to test for such agents on vaccine products are already specified in the monographs of the EP, and PCR is increasingly viewed as a suitable tool for the amplification and detection of extraneous nucleic acids in vaccines (Quintana et al., 2006; Bruckner & Ottiger, 2007) . Moreover, molecular biology methods are also considered of interest to detect infectious agent genomes in different products of animal origin used for human medicine, as it has been shown in the case of porcine circoviruses types 1 (PCV1) and 2 (PCV2) in a pepsin product of porcine origin (Fenaux et al., On: Fri, 28 Dec 2018 11:12:10 2004). Therefore, based on accumulated data on swine TTVs, apparently ubiquitous in pigs worldwide (Kekarainen & Segalés, 2008) , it would not be surprising to find these viruses (or components of them) in vaccine products for pig use, human medicines containing porcine products and standard enzymes used in laboratory analyses.
Specifically, six commercial vaccines for pigs resulted in being PCR positive for TTV. Most of the positive products were against M. hyopneumoniae. Those vaccines are produced using inactivated whole-cell preparations of the pathogen in the presence of porcine serum (Maes et al., 2008) . It is very likely that the porcine serum used during the manufacturing process of the biological product might be the source of TTVs, since the viral prevalence is high in the pig population (McKeown et al., 2004; Bigarré et al., 2005; Kekarainen et al., 2006; Martelli et al., 2006) . The source of TTV in PPV and PRRSV vaccines is unknown. However, since these vaccines are prepared by producing the pathogen in a suitable cell culture method, TTV might be inadvertently present in the initial inoculum, in the cell cultures and/or in the master seed stock. This contamina-tion process may be similar to that suggested for PCV1 in Aujeszky's disease virus (ADV) and combined PPV-ADV-Erysipelothrix rhusiopathiae vaccines (Quintana et al., 2006) . PCV1 is a contaminant of porcine-derived primary and continuous cell cultures (Tischer et al., 1986; Edwards & Sands, 1994) , which are often used to produce vaccines (Rivera et al., 1986; Katayama et al., 1998) .
Previously described, degenerate primers were also used to analyse the presence of TTV in the samples. Samples positive for one of the genogroup-specific PCRs also resulted positive with degenerate primers, indicating similar sensitivities of the two approaches. The degenerate primers are designed in two conserved regions of viral genome, resulting in amplification from 100 to 120 bp of swine TTV (Bigarré et al., 2005) . These primers allow simultaneous amplification of both, and even additional, swine TTV genogroups, but subsequent characterization always requires cloning and sequencing of the product. Furthermore, due to the short region analysed, it is likely that identification of different TTV genogroups or strains is not possible (Bigarré et al., 2005; Kekarainen et al., 2006) . Therefore, TTV genogroup-specific PCRs have been chosen as a routine assay in swine TTV diagnostics in this and other work performed in our laboratory Martinez et al., 2006; Kekarainen et al., 2007; Segalés et al., 2008) .
The sequence analysis revealed that the TTV strains present in the studied compounds were highly homologous with already published sequences. No specific clustering could be observed in the phylogenetic analysis. Therefore, obtained sequences probably represent the already known variability of TTVs observed in pigs, in accordance with earlier reports on swine TTV (Bigarré et al., 2005; Kekarainen et al., 2006) .
To rule out the presence of a given infectious agent genome from a vaccine product or a drug is not as easy as to run a PCR only. Therefore, all studied products giving negative results by corresponding PCRs were spiked with a known amount of a plasmid containing the amplicon detected by one of the PCR methods used (for TTV2). Finally, ten products (six drugs for human use, three swine vaccines and one enzyme) gave negative results after spiking. Lack of amplification in these products is most likely due to the presence of PCR inhibitors in the commercial vaccine/drug or remaining activity of the enzyme products. Common to all spiked PCR-negative vaccines was the presence of phenol or formaldehyde, which may be the cause of inhibition of the amplification product. On the other hand, most of the human drugs used contained heparin, which is a known inhibitor of PCR and it remains in the extracted DNA (Beutler et al., 1990; Yokota et al., 1999) . Thus, presence of TTV DNA cannot be reliably assessed in products containing PCR inhibitory substances.
Swine TTV1 has been detected in different pig tissues (Bigarré et al., 2005) . Therefore, the tested porcine heparins extracted from porcine mucosal tissues, and enzymes from Fig. 1 . Phylogenetic tree constructed based on the nucleotide sequences of the untranslated region of TTV1 and TTV2. 'V' indicates sequences derived from swine vaccines followed by the letter referring to the manufacturer and 'E' from elastase. The GenBank accession numbers for suggested prototypes for TTV1 (isolate Sd-TTV31, AB076001; isolate Sd-TTV1p, AY823990) and TTV2 (isolate Sd-TTV2p, AY823991) are included. GenBank accession numbers starting with DQ are TTV sequences from healthy pigs and animals affected by PMWS .
pancreas and stomach could, potentially, be positive for TTV PCRs. However, only enzymes derived from the pancreas resulted unequivocally in positive results.
It seems that the virus and/or its components are not removed during the product manufacturing. With currently available methods for TTV detection, including the lack of a cell-culture system for virus propagation as well as a standardized experimental model for the infection (Kekarainen & Segalés, 2008) , it is impossible to determine if the detected virus was still infectious. It is likely that inactivation steps during the manufacturing process inactivate viral particles, but still allow the detection of virus components by PCR. Noteworthy, inoculation of swine with DNA from another single-stranded circular DNA virus like PCV2 (full sequence) results in viraemia (Fenaux et al., 2002; Roca et al., 2004) , which potentially allows speculation about the infectiveness or not of DNA found in commercial products. However, experimental infection of pigs with PCV2 contaminated commercial pepsin product was unsuccessful . Moreover, the present study was based on the detection of TTV amplicons of about 300 (for TTV1) and 250 bp (for TTV2), which does not provide any evidence about the integrity of the viral genomes detected.
TTV is considered non-pathogenic in all species; however, there are several reports indicating its association with human diseases like autoimmune rheumatic diseases (Gergely et al., 2006) , liver pathologies (Nishizawa et al., 1997; Mushahwar et al., 1999; Kasirga et al., 2005) and respiratory conditions (Biagini et al., 2003; Maggi et al., 2003) . Recently, swine TTV was associated with PMWS . Interestingly, while PMWS affected pigs (91 %) were more likely to be infected with TTV2 than non-affected swine (72 %), no such difference was observed with genogroup 1 . It might be that distinct genogroups are having different pathogenetic capabilities. In the future, one possibility for commercial product manufacturing using porcine components would be the use of TTV-negative pigs as a source of raw material. However, this might prove to be difficult since most of the farms and animals are infected (Martelli et al., 2006; McKeown et al., 2004; Bigarré et al., 2005; Kekarainen et al., 2006) . Due to the putative role of TTV2 in disease, it is worthwhile to follow up commercial products and vaccines for virus contamination. However, before definitive proof for a TTV role in any disease is obtained, it should be considered as a non-pathogenic contaminant of swine-derived products.
Taking into account the ubiquitous nature of swine TTVs, it is possible to consider them as indicators of removal of contaminating viruses in manufacturing products containing porcine components, and it may be especially useful if novel pathogenic viruses are found in the future. On the other hand, although monographs of the EP are introducing new methods such as PCR to assess the potential existence of extraneous agents in vaccine and drug products, extensive validation of the methodology is needed for such purposes. The present work may represent the first step of this potential validation, since it indicates the existence of TTV contamination in commercial products for pig and human use as well as in laboratory enzymes.
